In this issue of the Journal, Qvarnstrom et al. [1] describe the development of a species-specific real-time polymerase chain reaction (PCR) assay that identifies a freeliving amoeba of the genus Sappinia, newly discovered to be a pathogen of the human central nervous system (CNS). Previously, species from 3 genera of freeliving amoebae had been associated with human infections [2] [3] [4] [5] [6] . Naegleria fowleri causes primary amoebic meningoencephalitis, a rapidly fatal hemorrhagic necrotizing infection of the CNS, which generally occurs in previously healthy children and young adults with a history of swimming and other recreational activities in warm freshwater lakes and ponds [2, 6] . Several species of Acanthamoeba cause granulomatous amoebic encephalitis (GAE), a chronic fatal disease of the CNS that is more commonly associated with immunocompromised states, particularly in patients who have undergone organ transplants, HIV-positive individuals, and individuals undergoing chemotherapy for cancer [3] [4] [5] 7] . Balamuthia mandrillaris can also cause GAE [3] .
Acanthamoeba and B. mandrillaris can also infect sites other than the CNS, causing pulmonary and cutaneous lesions [3] [4] [5] . Acanthamoeba can cause sightthreatening keratitis in immunocompetent individuals and is often associated with contact lens wear [4, 8] . These freeliving amoebae feed on bacteria and other microorganisms in the environment and are widely distributed in soil and water habitats. They also have been isolated from domestic water supplies, wells, dental irrigation units, hospital water supplies, and air conditioning units [4, 9 -13] . In addition to causing serious infections, free-living amoebae also may serve as reservoirs in the environment for pathogenic bacteria such as Legionella pneumophila and Mycobacterium avium [14, 15] . Exposure to free-living amoebae appears to be common, since studies have shown that serum samples from adult humans contain antibodies to N. fowleri, Acanthamoeba species, and B. mandrillaris [16 -18] . However, it is not known why disease occurs in some individuals but not in others. The dose and strain of amoebae to which an individual is exposed may be factors involved in susceptibility. Defects in the host's innate or acquired immunity may also play roles in susceptibility to infection [3, 5, 6] .
In 2001, Gelman et al. [19] described a nonfatal case of amoebic encephalitis that was attributed to a free-living amoeba that had not previously been associated with human disease. A previously healthy, 38-year-old, immunocompetent male presented with a history of nausea, vomiting, headache, loss of consciousness, and photophobia following a sinus infection. Brain images produced by magnetic resonance imaging showed a solitary mass in the temporal lobe. Microscopic examination of the excised lesion revealed the presence of amoebic trophozoites that contained 2 apposed nuclei, a morphologic feature of the free-living amoeba Sappinia diploidea. Immunofluorescence microscopy that used antibodies to N. fowleri, Acanthamoeba species, and B. mandrillaris excluded these agents as the cause of the infection. The patient survived the infection after treatment with a combination of azithromycin, pentamidine, itraconazole, and flucytosine. Further characterization was not undertaken because live amoebae were not recovered from the patient. Neither were amoebae isolated from cerebrospinal fluid or biopsy tissue samples. Thus, on the basis of morphologic criteria, immunofluorescence assessment, and a nonfatal patient outcome, the CNS infection was attributed to S. diploidea [19, 20] .
Identification of amoebae on the basis of morphological criteria is difficult and unreliable. Acanthamoeba and B. mandrillaris can be difficult to differentiate in tissues because they are similar in structure. Biochemical techniques, such as protein and isoenzyme profiles, have proven useful for distinguishing pathogenic and nonpathogenic species of some freeliving amoebae. Immunological assays that use monoclonal or polyclonal antibodies in conjunction with immunofluo-rescence or Western blot analysis also may be useful. However, molecular techniques have proven more specific and reliable, and a number of specific and sensitive PCR assays have been developed to identify Naegleria, B. mandrillaris, and Acanthamoeba in the environment and in human tissues. Many of these assays are based on the sequence of 18S rRNA genes or on specific cDNA sequences [21] [22] [23] [24] [25] . In particular, the sequencing of 18S rRNA genes is being used to identify species of free-living amoebae because rDNA is the most conserved region in the genome and allows for determination of phylogenetic divergence. The examination of small subunit ribosomal DNA has been used to establish taxonomic relationships among many protozoa, including amoebae. Biopsy specimens of brain tissue or cerebral spinal fluid in which trophozoites or cysts may be present can be used to isolate amoebic DNA for use in these PCR assays.
In their current article, Qvarnstrom et al. [1] describe the development of a species-specific duplex TaqMan PCR assay that allows researchers to discriminate between the 2 known species of Sappinia, S. pedata and S. diploidea. The authors used a 2-step approach to obtain a species-specific identification of the Sappinia amoeba reported by Gelman et al. [19, 20] . First, they used an assay that detects Sappinia at the genus level through amplification of the complete chromosomal 18S rRNA gene, by use of generic eukaryotic primers alone and in combination with amoeba-specific primers to ensure that the amoeba originally identified in brain tissue samples from this unusual case was appropriately assigned to the genus. Then, they proceeded to discriminate between species within the genus. Using 2 strains of Sappinia that were provided by Michel [26] and presumed to be S. diploidea, the authors were able to distinguish differences in the sequence of the 18S ribosomal gene. The sequence of one strain was found to be identical to that of the GenBank entry for S. diploidea, whereas the sequence of the second strain exhibited 97%-98% identity to the entry for S. pedata [27] . By use of these sequence data, 2 sets of primers and TaqMan probes were designed specifically to detect S. diploidea and S. pedata. A species-specific duplex TaqMan PCR assay was then used to test a tissue sample from the patient with GAE described by Gelman et al. [19, 20] ; results showed that the sample was negative for S. diploidea while exhibiting specific priming sites for S. pedata. On the basis of these results, the authors concluded that the amoebae that caused GAE in the patient were most likely a strain of S. pedata.
The assay that has been developed can be used on isolated amoebae as well as on tissue specimens. To verify the specificity of the real time PCR assay for the identification of Sappinia, 34 clinical specimens consisting of brain tissue or cerebrospinal fluid from patients with suspected cases of amoebic encephalitis and negative controls consisting of bacterial organisms were used. Furthermore, the PCR procedure for Sappinia can be incorporated into a multiplex real-time PCR assay that had been developed for the simultaneous detection of Acanthamoeba, B. mandrillaris, and N. fowleri [24] . Thus, the availability of multiplex PCR assays means that a more rapid diagnosis may be made, so that treatment of patients can be started earlier.
Sappinia has a worldwide distribution and has been isolated from animal feces, dead plant material, tree bark, and soil [26 -29] . The 2 named species in the genus, S. pedata and S. diploidea, have 2 forms in their life cycle, a trophozoite and a cyst, both stages of which can be found in the environment and in human tissue. However, the 2 species are morphologically similar, and identification of amoebae on the basis of morphological criteria is unreliable. Furthermore, few studies have been performed on Sappinia species and until recently immunological and molecular tests had not been developed to identify Sappinia in human tissue. Although diseases caused by free-living amoebae are rare, there has been an increase in the number of reported cases in recent years [30] . In addition, there is concern about these diseases since the mortality rate is high as a result of failure to recognize the causative agent, which results in delays in diagnosis and treatment. The finding that S. pedata, a heretofore unrecognized human pathogen, can cause a CNS infection in immunocompetent individuals is significant in that it should alert clinicians and diagnosticians to consider amoebic encephalitis as a cause of chronic or fatal CNS disease. Successful treatment of these diseases, although rare, has occurred [2] [3] [4] [5] . Thus, greater awareness of known amoebic pathogens along with the finding of newly recognized amoebic pathogens and the development of PCR assays, such as that reported by Qvarnstrom et al. [1] , may lead to earlier diagnosis and treatment.
